Literature DB >> 31392163

The risk of oversimplification in risk-stratification of neoadjuvant chemotherapy-responses in muscle invasive bladder cancer.

Amir Sherif1.   

Abstract

Entities:  

Year:  2019        PMID： 31392163      PMCID： PMC6642970          DOI： 10.21037/tau.2019.05.03

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  16 in total

1.  Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.

Authors:  Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Journal:  Eur Urol       Date:  2006-06-08       Impact factor: 20.096

2.  Detection of immune responses against urinary bladder cancer in sentinel lymph nodes.

Authors:  Per Marits; Mona Karlsson; Amir Sherif; Ulrike Garske; Magnus Thörn; Ola Winqvist
Journal:  Eur Urol       Date:  2005-11-14       Impact factor: 20.096

3.  Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.

Authors:  Robert Rosenblatt; Amir Sherif; Erkki Rintala; Rolf Wahlqvist; Anders Ullén; Sten Nilsson; Per-Uno Malmström
Journal:  Eur Urol       Date:  2011-12-13       Impact factor: 20.096

4.  Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Authors: 
Journal:  Eur Urol       Date:  2005-04-21       Impact factor: 20.096

5.  International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Authors:  Gareth Griffiths; Reginald Hall; Richard Sylvester; Derek Raghavan; Mahesh K B Parmar
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

6.  Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.

Authors:  Polat Turker; Peter J Bostrom; Marcelo L Wroclawski; Bas van Rhijn; Hannes Kortekangas; Cynthia Kuk; Tuomas Mirtti; Neil E Fleshner; Michael A Jewett; Antonio Finelli; Theo Vander Kwast; Andy Evans; Joan Sweet; Matti Laato; Alexandre R Zlotta
Journal:  BJU Int       Date:  2012-02-09       Impact factor: 5.588

7.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Authors:  H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

8.  Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.

Authors:  Stephen H Culp; Rian J Dickstein; H Barton Grossman; Shanna M Pretzsch; Sima Porten; Siamak Daneshmand; Jie Cai; Susan Groshen; Arlene Siefker-Radtke; Randall E Millikan; Bogdan Czerniak; Neema Navai; Matthew F Wszolek; Ashish M Kamat; Colin P N Dinney
Journal:  J Urol       Date:  2013-07-30       Impact factor: 7.450

9.  Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

Authors:  J Alfred Witjes; Thierry Lebret; Eva M Compérat; Nigel C Cowan; Maria De Santis; Harman Maxim Bruins; Virginia Hernández; Estefania Linares Espinós; James Dunn; Mathieu Rouanne; Yann Neuzillet; Erik Veskimäe; Antoine G van der Heijden; Georgios Gakis; Maria J Ribal
Journal:  Eur Urol       Date:  2016-06-30       Impact factor: 20.096

10.  Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.

Authors:  Amir Sherif; Lars Holmberg; Erkki Rintala; Oddvar Mestad; Jonas Nilsson; Sten Nilsson; Per-Uno Malmström
Journal:  Eur Urol       Date:  2004-03       Impact factor: 20.096
View more
  1 in total

1.  Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.

Authors:  Stephanie A Harmon; Thomas H Sanford; G Thomas Brown; Chris Yang; Sherif Mehralivand; Joseph M Jacob; Vladimir A Valera; Joanna H Shih; Piyush K Agarwal; Peter L Choyke; Baris Turkbey
Journal:  JCO Clin Cancer Inform       Date:  2020-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.